Meningoencephalomyelitis Associated With Vimentin IgG Autoantibodies
1 clinical trials · Condition
◉ Watch Meningoencephalomyelitis Associated With Vimentin IgG Autoantibodies
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Rituximab in the Treatment of Anti-Vimentin Antibody-associated Diseases (NCT07051070) | Xuanwu Hospital, Beijing | 2025-07-01 |
Track Meningoencephalomyelitis Associated With Vimentin IgG Autoantibodies automatically
Every clearance here is in the API, with alerts when new ones post.